SciClone Pharmaceuticals (SCLN)
Add to Watchlists Create an Alert
4.86
-0.11 -2.21%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
SciClone Pharmaceuticals Revenue Quarterly:
33.14M for Dec. 31, 2012SciClone Pharmaceuticals Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 33.14M |
| Sept. 30, 2012 | 40.69M |
| June 30, 2012 | 41.37M |
| March 31, 2012 | 41.07M |
| Dec. 31, 2011 | 39.68M |
| Sept. 30, 2011 | 39.30M |
| June 30, 2011 | 31.93M |
| March 31, 2011 | 21.66M |
| Dec. 31, 2010 | 23.62M |
| Sept. 30, 2010 | 22.84M |
| June 30, 2010 | 20.69M |
| March 31, 2010 | 17.96M |
| Dec. 31, 2009 | 18.13M |
| Sept. 30, 2009 | 17.24M |
| June 30, 2009 | 21.97M |
| March 31, 2009 | 15.07M |
| Dec. 31, 2008 | 15.32M |
| Sept. 30, 2008 | 14.33M |
| June 30, 2008 | 13.83M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
SCLN Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| Lannett Company | 39.02M |
| DepoMed | 26.59M |
| POZEN | 1.352M |
SCLN Revenue Quarterly Rankings
| Overall |
59th percentile 3274 of 8011 |
| Sector |
66th percentile 230 of 687 in Healthcare |
| Industry |
66th percentile 23 of 69 in Drug Manufacturers - Specialty & Generic |
SCLN Revenue Quarterly Range, Past 5 Years
| Minimum | 13.83M | Jun 2008 |
| Maximum | 41.37M | Jun 2012 |
| Average | 25.78M |